Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review. [PDF]
Wang Y +4 more
europepmc +1 more source
AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. [PDF]
Cuffari B.
europepmc +1 more source
Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges. [PDF]
Shi W +9 more
europepmc +1 more source
Quantitative Bone Scintigraphic Follow-Up After a 2-Month Cross-Training Program Including Swimming in Showjumping Horses with Back and Neck Pain. [PDF]
Prémont A +6 more
europepmc +1 more source
Automatic Delineation of Tumor Spheroids in Microscopic Images Using Deep-Learning
Jens Maus +9 more
doaj +1 more source
Clinical Trial Protocol for LPS-Boost: Intensified [<sup>177</sup>Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease. [PDF]
Iravani A +27 more
europepmc +1 more source
Optimization of Gravity Infusion Protocols for <sup>177</sup>Lu-DOTATATE Administration in Peptide Receptor Radionuclide Therapy. [PDF]
Grasso S +14 more
europepmc +1 more source
The next evolution of theranostics: from target discovery to integrated precision medicine. [PDF]
Montemagno C, Serrano B, Paulmier B.
europepmc +1 more source
Artificial Intelligence in Nuclear Medicine (2015-2025): Clinical Applications, Regulatory Governance, and Pharmacotherapeutic Implications. [PDF]
Alpizar-Rojas M +6 more
europepmc +1 more source
Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [<sup>11</sup>C]AZ14193391. [PDF]
Törnblom A +10 more
europepmc +1 more source

